Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Optimal designs for estimating penetrance of rare mutations of a disease-susceptibility gene.

Gong G, Whittemore AS.

Genet Epidemiol. 2003 Apr;24(3):173-80.

PMID:
12652521
2.
3.

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.

Antoniou AC, Durocher F, Smith P, Simard J, Easton DF; INHERIT BRCAs program members.

Breast Cancer Res. 2006;8(1):R3. Epub 2005 Dec 12.

4.

Estimating disease risk associated with mutated genes in family-based designs.

Choi YH, Kopciuk KA, Briollais L.

Hum Hered. 2008;66(4):238-51. doi: 10.1159/000143406. Epub 2008 Jul 9.

PMID:
18612208
5.
6.
7.
8.

Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations.

Marroni F, Aretini P, D'Andrea E, Caligo MA, Cortesi L, Viel A, Ricevuto E, Montagna M, Cipollini G, Federico M, Santarosa M, Marchetti P, Bailey-Wilson JE, Bevilacqua G, Parmigiani G, Presciuttini S.

Eur J Hum Genet. 2004 Nov;12(11):899-906.

9.

Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.

Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjörd JE.

J Natl Cancer Inst. 2006 Jan 18;98(2):116-22.

PMID:
16418514
10.

The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.

Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Díez O, Alonso MC, Lazaro C, Blanco I, Sánchez-de-Abajo A, Caldés T, Blanco A, Graña B, Durán M, Velasco E, Chirivella I, Cardeñosa EE, Tejada MI, Beristain E, Miramar MD, Calvo MT, Martínez E, Guillén C, Salazar R, San Román C, Antoniou AC, Urioste M, Benítez J.

Clin Cancer Res. 2008 May 1;14(9):2861-9. doi: 10.1158/1078-0432.CCR-07-4436.

11.

Estimating risk of breast cancer in carriers of BRCA1 and BRCA2 mutations: a meta-analytic approach.

Fu R, Harris EL, Helfand M, Nelson HD.

Stat Med. 2007 Apr 15;26(8):1775-87.

PMID:
17243094
12.

Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.

Gallardo M, Silva A, Rubio L, Alvarez C, Torrealba C, Salinas M, Tapia T, Faundez P, Palma L, Riccio ME, Paredes H, Rodriguez M, Cruz A, Rousseau C, King MC, Camus M, Alvarez M, Carvallo P.

Breast Cancer Res Treat. 2006 Jan;95(1):81-7. Epub 2005 Oct 27.

PMID:
16261400
13.
14.

BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.

Lalloo F, Varley J, Moran A, Ellis D, O'dair L, Pharoah P, Antoniou A, Hartley R, Shenton A, Seal S, Bulman B, Howell A, Evans DG.

Eur J Cancer. 2006 May;42(8):1143-50. Epub 2006 Apr 27.

PMID:
16644204
15.

Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.

Bonadona V, Sinilnikova OM, Chopin S, Antoniou AC, Mignotte H, Mathevet P, Brémond A, Martin A, Bobin JY, Romestaing P, Raudrant D, Rudigoz RC, Léoné M, Chauvin F, Easton DF, Lenoir GM, Lasset C.

Genes Chromosomes Cancer. 2005 Aug;43(4):404-13.

PMID:
15887246
16.

Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL.

J Natl Cancer Inst. 2002 Sep 18;94(18):1365-72.

PMID:
12237282
17.

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.

Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF.

J Med Genet. 2005 Jul;42(7):602-3.

18.

Age-dependent penetrance of different germline mutations in the BRCA1 gene.

Al-Mulla F, Bland JM, Serratt D, Miller J, Chu C, Taylor GT.

J Clin Pathol. 2009 Apr;62(4):350-6. doi: 10.1136/jcp.2008.062646.

19.

Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models.

Roudgari H, Miedzybrodzka ZH, Haites NE.

Fam Cancer. 2008;7(3):199-212. Epub 2007 Dec 21.

PMID:
18097771
20.

Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred.

Vogl FD, Badzioch MD, Steele L, Neuhausen SL, Goldgar DE.

Fam Cancer. 2007;6(1):63-71.

PMID:
17051349

Supplemental Content

Support Center